| 000 | 01706 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514052935.0 | ||
| 264 | 0 | _c20030116 | |
| 008 | 200301s 0 0 eng d | ||
| 022 | _a0002-9440 | ||
| 024 | 7 |
_a10.1016/S0002-9440(10)64476-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan de Rijn, Matt | |
| 245 | 0 | 0 |
_aExpression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. _h[electronic resource] |
| 260 |
_bThe American journal of pathology _cDec 2002 |
||
| 300 |
_a1991-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aBreast _xcytology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aKeratin-5 |
| 650 | 0 | 4 |
_aKeratins _xgenetics |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPerou, Charles M | |
| 700 | 1 | _aTibshirani, Rob | |
| 700 | 1 | _aHaas, Phillippe | |
| 700 | 1 | _aKallioniemi, Olli | |
| 700 | 1 | _aKononen, Juha | |
| 700 | 1 | _aTorhorst, Joachim | |
| 700 | 1 | _aSauter, Guido | |
| 700 | 1 | _aZuber, Markus | |
| 700 | 1 | _aKöchli, Ossi R | |
| 700 | 1 | _aMross, Frank | |
| 700 | 1 | _aDieterich, Holger | |
| 700 | 1 | _aSeitz, Rob | |
| 700 | 1 | _aRoss, Doug | |
| 700 | 1 | _aBotstein, David | |
| 700 | 1 | _aBrown, Pat | |
| 773 | 0 |
_tThe American journal of pathology _gvol. 161 _gno. 6 _gp. 1991-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0002-9440(10)64476-8 _zAvailable from publisher's website |
| 999 |
_c12271411 _d12271411 |
||